ScarAway Buy Builds Perrigo Value, But Not A Wall Against Mylan
This article was originally published in The Tan Sheet
Perrigo’s acquisition of the ScarAway brand is not enough to ward off Mylan’s hostile takeover bid but it could be one of several in the near term that would add more value in an attempt to deter Mylan. A large deal likely would be more effective, but Irish securities regulations limit Perrigo’s options with Mylan’s tender pending.
You may also be interested in...
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.
P&G approach to advertising for SK-II skin care drove double-digit sales growth in new users and prompted a 27% increase in searches for the line. P&G has saved $1bn from cost-cutting in ad agencies and advertising implemented over past five years, says chief brand officer Marc Pritchard.
HBW Market News: DSM Taps Co-CEOs, Bayer Consumer Ex-US Changes Ad Firm, Recover 180° Sponsors Champ, More
Former PepsiCo exec Beraud's Sh’nnong Beverage launches Ma Functional Iced Teas with CBD+ Natural Botanicals; Chobani expands beyond yogurt with oat-based products; Recover 180° sponsors boxer Deontay Wilder; Mighty Self Balance CBD targets inflammation; Oki CBD drinks reach Florida; Bayer consumer taps ad firm MullenLowe; and Royal DSM will have co-CEOs when CEO Sijbesma leaves.